<!DOCTYPE html>
<html>
  <head>
    <title>Glaucoma</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/eyes/">eyes</a></li>
      <li class="active">Glaucoma</li>
  </ol>

  <div class="page-header">
 
    <h1>Glaucoma</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Glaucoma</strong></a>
          <div class="toc">
<ul>
<li><a href="#open-angle-glaucoma">Open-angle glaucoma</a><ul>
<li><a href="#primary-open-angle-glaucoma">Primary open-angle glaucoma</a></li>
<li><a href="#secondary-open-angle-glaucoma">Secondary open-angle glaucoma</a></li>
</ul>
</li>
<li><a href="#angle-closure-glaucoma">Angle-closure glaucoma</a><ul>
<li><a href="#intermittent-angle-closure-glaucoma">Intermittent angle-closure glaucoma</a></li>
<li><a href="#chronic-angle-closure-glaucoma">Chronic angle-closure glaucoma</a></li>
</ul>
</li>
<li><a href="#risk-factors">Risk factors</a></li>
<li><a href="#diagnosis">Diagnosis</a></li>
<li><a href="#management">Management</a><ul>
<li><a href="#monitoring-long-term">Monitoring long term</a></li>
</ul>
</li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <blockquote>
<p>leading cause of preventable blindness in NZ</p>
</blockquote>
<ul>
<li>
<p>group of pregoressive conditions</p>
<ul>
<li>damage to the optic nerve and a reduction in visual field</li>
</ul>
</li>
<li>
<p>all forms of glaucoma can lead to irreversible los sof vision</p>
</li>
<li>
<p>chronic glaucoma = asymptomatic until advanced</p>
</li>
<li>
<p>increased risk:</p>
<ul>
<li>
<p>>45</p>
</li>
<li>
<p>family history of glaucoma</p>
</li>
</ul>
</li>
<li>
<p>treatment is not curative;</p>
<ul>
<li>does slow progressive visual loss</li>
</ul>
</li>
<li>
<p>raised intraocular pressure (>21mmHg) no longer defining characteristic of glaucoma</p>
<ul>
<li>1/3 >55yo had IOP \&lt;21</li>
</ul>
</li>
</ul>
<blockquote>
<p>optic neuropathy for which ocular hypertension is most important risk factor</p>
</blockquote>
<ul>
<li>
<p>reducing IOP only pharmacological strategy for slowing progression</p>
<ul>
<li>including with IOP normal levels</li>
</ul>
</li>
<li>
<p>pathophysiology:</p>
<ul>
<li>
<p>ganglion cell axons damaged at optic nerve head</p>
<ul>
<li>
<p>most ant. section visible</p>
</li>
<li>
<p>characteristic <strong>cupped</strong> appearance</p>
</li>
</ul>
</li>
<li>
<p>typical patttern of visual field loss</p>
<ul>
<li>
<p>arcuate scotoma</p>
<ul>
<li>sparing of the centre - vignette (black)</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="open-angle-glaucoma">Open-angle glaucoma</h3>
<ul>
<li>
<p>trabecular meshwork becomes blocked over time or tissues around it harden</p>
<ul>
<li>preventing drainage of aqueous humour from anterior chamber of eye</li>
</ul>
</li>
</ul>
<h4 id="primary-open-angle-glaucoma">Primary open-angle glaucoma</h4>
<ul>
<li>
<p>most common form of glaucoma</p>
</li>
<li>
<p>90% in developed countries</p>
</li>
<li>
<p>if normal pressure = “normal tension glaucoma”</p>
</li>
</ul>
<h4 id="secondary-open-angle-glaucoma">Secondary open-angle glaucoma</h4>
<ul>
<li>
<p>most often caused by pseudoexfoliation syndrome</p>
<ul>
<li>
<p>deposition of flaky, white protein fibres within the anterior segment of the eye</p>
<ul>
<li>resulting in trabecular meshwork becoming blocked</li>
</ul>
</li>
</ul>
</li>
<li>
<p>genetic component</p>
</li>
<li>
<p>also</p>
<ul>
<li>
<p>UV light</p>
</li>
<li>
<p>oxidative stress</p>
</li>
<li>
<p>infection and inflammation</p>
</li>
</ul>
</li>
<li>
<p>common with increasing age</p>
<ul>
<li>\~25% of people >60yo</li>
</ul>
</li>
<li>
<p>Eye trauma can cause neovascular open-angle glaucoma</p>
<ul>
<li>
<p>blunt or penetrating</p>
<ul>
<li>immediately -> years later</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Corticosteroids</p>
<ul>
<li>
<p>oral, nasal, ocular routes</p>
</li>
<li>
<p>raise IOP</p>
</li>
<li>
<p>most common cuase of medicine-induced glaucoma</p>
</li>
</ul>
</li>
</ul>
<h3 id="angle-closure-glaucoma">Angle-closure glaucoma</h3>
<blockquote>
<p>medical emergency - disucss immediately</p>
</blockquote>
<ul>
<li>
<p>usually treated by laser iridotomy once IOP and any inflammation have been stabilised</p>
</li>
<li>
<p>rare</p>
<ul>
<li>
<p>narrow ocular drainage angle</p>
</li>
<li>
<p>thicker lens</p>
</li>
<li>
<p>thinner iris</p>
</li>
</ul>
</li>
<li>
<p>IOP can be incincrease 70mmHg</p>
<ul>
<li>permanent damage to ganglion cells in days - weeks</li>
</ul>
</li>
<li>
<p>common causes</p>
<ul>
<li>
<p>often occur when watching TV in dim lighting</p>
</li>
<li>
<p>during periods of acute stress or excitement</p>
</li>
<li>
<p>adverse effect of atropine following surgery</p>
</li>
</ul>
</li>
<li>
<p>common symptoms</p>
<ul>
<li>
<p>intense deep eye pain</p>
</li>
<li>
<p>blurred vision</p>
</li>
<li>
<p>headache</p>
</li>
<li>
<p>nausea</p>
</li>
<li>
<p>vomiting</p>
</li>
</ul>
</li>
<li>
<p>signs</p>
<ul>
<li>
<p>ciliary injection</p>
</li>
<li>
<p>fixed mid-dilated pupil</p>
</li>
<li>
<p>hazy cornea</p>
</li>
<li>
<p>decrease visual acuity</p>
</li>
</ul>
</li>
<li>
<p>uncommonly in both eyes</p>
</li>
<li>
<p>increase risk of developing same in other eye in future</p>
</li>
</ul>
<h4 id="intermittent-angle-closure-glaucoma">Intermittent angle-closure glaucoma</h4>
<ul>
<li>
<p>series of minor acute angle-closure episodes</p>
<ul>
<li>angle of drainage becoming partially or intermittently blocked</li>
</ul>
</li>
</ul>
<h4 id="chronic-angle-closure-glaucoma">Chronic angle-closure glaucoma</h4>
<ul>
<li>
<p>drainage meshwork occluded by iris synechiae</p>
<ul>
<li>
<p>gradually without acute symptoms</p>
</li>
<li>
<p>minimic priamry open-angle claucoma</p>
</li>
</ul>
</li>
</ul>
<h3 id="risk-factors">Risk factors</h3>
<ul>
<li>
<p>increased IOP - most significant rsk factor</p>
</li>
<li>
<p>10% with ocular HTN devlop open angle glaucoma within 5yrs</p>
</li>
<li>
<p>risk reduced by intervention</p>
</li>
<li>
<p>Advanced age</p>
</li>
<li>
<p>family hisotry</p>
</li>
<li>
<p>myopia requring optical correction</p>
<ul>
<li>
<p>stronger myopia</p>
</li>
<li>
<p>higher likelihood patient will develop glaucoma</p>
</li>
</ul>
</li>
<li>
<p>diabetes</p>
<ul>
<li>twice risk </li>
</ul>
</li>
<li>
<p>African decent</p>
</li>
<li>
<p>use of corticosteroid</p>
<ul>
<li>
<p>increase  expression of myocilin gene</p>
</li>
<li>
<p>long-term corticosteroid (>10mg prednisone) for periods of >2mo should be considered for referral to an Optometrist or Opthalmologist for eye assessment</p>
</li>
</ul>
</li>
</ul>
<h3 id="diagnosis">Diagnosis</h3>
<ul>
<li>
<p>primarily by optomotrist/opthalmologist</p>
</li>
<li>
<p>opthalmoscopy = limited role</p>
<ul>
<li>
<p>2 dimensions</p>
</li>
<li>
<p>increase cup to disk ratio (verticla ratio >0.6)</p>
</li>
<li>
<p>thinning and/or notching of neuroretinal rim</p>
</li>
<li>
<p>flame-shaped disk haemorrhage</p>
</li>
</ul>
</li>
<li>
<p>ideally aged >45yo have full eye assessment</p>
</li>
<li>
<p>if at risk or suspected = refer optomotrist</p>
</li>
</ul>
<h3 id="management">Management</h3>
<ul>
<li>
<p>reducing IOP = focus</p>
</li>
<li>
<p>iniital drop in IOP may occur within minute - hours of medicine administration</p>
</li>
<li>
<p>step wise:</p>
<ul>
<li>
<p>Prostaglandin analogues - increase uveoscleral outflow</p>
<ul>
<li>
<p>first choice</p>
</li>
<li>
<p>once dialy (evening)</p>
</li>
</ul>
</li>
<li>
<p>beta-blockers - reduce production of aquesous huymour</p>
</li>
<li>
<p>sympathomimetics (a2 agonists) dec aquous humour produciton and increase uveoscleral outflow</p>
</li>
<li>
<p>Carbonic anhydrase inhibitors - decrease production of aqueous humour</p>
</li>
<li>
<p>cholinrgics - miotics - increase trabecular outflow</p>
</li>
</ul>
</li>
<li>
<p>Double DOT</p>
<ul>
<li>
<p>digital occulsion of tear duct and don’t open technique</p>
</li>
<li>
<p>preferred method</p>
</li>
<li>
<p>maximises efficacy and reduces systemic absorption by up to 70%</p>
</li>
<li>
<p>drop placed in eye with head horizontal</p>
<ul>
<li>
<p>immediately after</p>
<ul>
<li>
<p>eye closed</p>
</li>
<li>
<p>forefinger placed in corner of eye</p>
<ul>
<li>
<p>(against nose)</p>
</li>
<li>
<p>for at least 2 minutes</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>sit or lie in supine position = easier for elderly periods</p>
</li>
<li>
<p>5minutes between differnet medications</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>soft contact lesn removed = can absorb components of solution</p>
</li>
<li>
<p>eye -> nasolacrimal duct into nose</p>
</li>
<li>
<p>readily/rapid absoption</p>
<ul>
<li>without first pass metabolism</li>
</ul>
</li>
<li>
<p>topical beta blockers will produce some degree of systemic blockade</p>
</li>
<li>
<p>consider acetozolamide</p>
<ul>
<li>CI in severe heart failure</li>
</ul>
</li>
<li>
<p>betablockers</p>
<ul>
<li>
<p>systemic absoprtion</p>
</li>
<li>
<p>asthma</p>
</li>
<li>
<p>hypo awareness</p>
</li>
<li>
<p>decrease awareness of hyperthyroidism</p>
</li>
</ul>
</li>
</ul>
<h4 id="monitoring-long-term">Monitoring long term</h4>
<ul>
<li>
<p>3-12 mo by opthalmologist</p>
</li>
<li>
<p>ensure persisting with treatment</p>
</li>
<li>
<p>confirm patient using Double DOT method</p>
</li>
<li>
<p>Review any new diagnoses or treatments that may interact with glaucoma treatmnet</p>
</li>
<li>
<p>confirm attending f/u</p>
</li>
<li>
<p>ensure patient disucssed with family</p>
</li>
</ul>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
